Related content

Reply to comparative analysis of GATA3 mutation profiles between Asian and Western patients with breast cancer: Is there really a difference?

By Zuo Wenjia   Yu Ke-Da   Shao Zhi-Ming  

Cancer, Vol. 120, Iss. 17, 2014-09 ,pp. : 2779-2780

Blackwell Publishing

Access to resources Recommend Favorite

GATA3 mutations define a unique subtype of luminal-like breast cancer with improved survival

By Jiang Yi-Zhou   Yu Ke-Da   Zuo Wen-Jia   Peng Wen-Ting   Shao Zhi-Ming  

Cancer, Vol. 120, Iss. 9, 2014-05 ,pp. : 1329-1337

Blackwell Publishing

Access to resources Recommend Favorite

Novel SLC22A16 polymorphisms and influence on doxorubicin pharmacokinetics in Asian breast cancer patients

By Lal Suman   Wong Zee Wan   Jada Srinivasa Rao   Xiang Xiaoqiang   Chen Shu Xiao   Ang Peter Cher Siang   Figg William D   Lee Edmund JD   Chowbay Balram  

Pharmacogenomics, Vol. 8, Iss. 6, 2007-06 ,pp. : 567-575

Future Medicine

Access to resources Recommend Favorite

Tailoring Therapy for Locally Advanced Breast Cancer Using Molecular Profiles: Are We There Yet?

By Fosker Christopher  

Drugs, Vol. 71, Iss. 15, 2011-10 ,pp. : 1947-1955

Adis International

Access to resources Recommend Favorite

Comparative Proteomics Analysis of SKBR3 and MCF7 Breast Cancer Cell Lines Using Two Dimensional Electrophoresis: Ready to Build Postgenomics Capacity for OMICS R&D in Developing Countries?

By  

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 10, Iss. 2, 2012-06 ,pp. : 132-137

Bentham Science Publishers

Access to resources Recommend Favorite